A Prospective Validation Study of Radiomics in the Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma
NCT07269535
AI (Artificial Intelligence), Leiomyoma
View Trial DetailsNCT Number: NCT05840042
Uterine fibroids are the most common form of benign uterine tumors in the uterine muscle layer, which had a certain rate of malignancy, but it is rare. The prevalence of uterine fibroids estimates range from 4.5% to 68.6% depending on study population and diagnostic methodology. The prevalence of fibroids has been historically underestimated by epidemiologic studies which focused mainly on symptomatic women, leaving behind a large population of asymptomatic women and women who underreport their symptoms. What investigators don't know was which women who have fibroids will develop clinical symptoms and which women who have an operation of myomectomy will relapse. The purpose of this study is to investigate the prevalence, incidence and risk factors for the development of uterine fibroids in Chinese women.
Trial opening soon.
Get Notified18 year and older
Female
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Time frame: Baseline
Prevalence of uterine fibroids in China
Time frame: Two follow-ups over a three-year period
Incidence of uterine fibroids in China
Time frame: Two follow-ups over a three-year period
Associated risk factors for recurrence, infertility and malignancy of uterine fibroids in China
Contact information is provided by the study sponsor or research team.
Shixuan Wang
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07269535
AI (Artificial Intelligence), Leiomyoma
View Trial DetailsNCT06153667
Leiomyoma, Neoplasms
Brooklyn, New York, United States
View Trial DetailsNCT04345003
Leiomyoma, Neoplasms
Bordeaux, France
View Trial DetailsNCT06430320
Leiomyoma, Neoplasms
San Francisco, California, United States
View Trial Details